Machine Learning-Guided Training for Elite Athletes (MLGT)

Debre Berhan University120 enrolled

Overview

Plaintext The purpose of this study is to evaluate whether a personalized training protocol driven by machine learning can successfully reduce time-loss sports injuries and enhance athletic performance in elite athletes. During a 9-month competitive sports season, a group of elite athletes was divided into two training

This study evaluated the efficacy of an adaptive, machine learning-driven training protocol compared to traditional athletic preparation over a full 9-month competitive sports season. The primary objective was to determine if a dynamic, technology-led approach to training load management could minimize time-loss injuries while concurrently optimizing athletic performance markers. Participants were elite athletes randomly allocated into two parallel groups: 1. The Experimental Group, which underwent training regimens dynamically adjusted using a machine learning algorithm that analyzed individual biomechanical data and historical workload parameters to optimize training volume and intensity. 2. The Control Group, which followed standard, predetermined high-performance athletic training protocols typical for competitive season preparation. Throughout the 9-month intervention period, daily tracking was maintained by technical and coaching staff. Data collection focused on the incidence, severity, and duration of all time-loss sports injuries. Concurrently, sport-specific performance parameters were periodically assessed to evaluate physical conditioning and competitive readiness. Statistical analyses were subsequently conducted to compare cumulative injury rates, total days lost to injury, and net performance adaptations between the two cohorts.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

120

Conditions

Athletic Injuries

Interventions

Adaptive Machine Learning Workload OptimizationBEHAVIORAL

A personalized, data-driven training intervention where athletic workloads are dynamically adjusted based on predictive modeling. The protocol continuously tracks individual physiological markers, biomechanical data, and workload history to optimize training volume and intensity. This adaptive approach aims to maximize performance gains while minimizing the risk of overtraining and injury during the competitive season.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 35 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. Must be a competitive, elite-level or sub-elite track and field athlete specializing in short-to-mid distance running events. 2. Aged between 18 and 35 years old. 3. Actively participating in structured athletic training programs for at least 2 years prior to enrollment. 4. Free from any acute musculoskeletal injuries or medical conditions that prevent full participation in high-intensity training protocols. 5. Capable and willing to provide written informed consent to participate in the study. Exclusion Criteria: 1. Current or recent (within the past 3 months) major lower-limb injury or surgery that restricts maximal sprint or aerobic performance. 2\. Concurrent use of performance-enhancing drugs or medications that influence metabolic or cardiovascular responses. 3\. Inability to maintain consistent participation in the designated training protocols due to scheduling conflicts or travel. 4\. Any underlying cardiovascular, respiratory, or systemic condition that creates a health risk during exhaustive exercise testing.

Locations (2)

Dr. Arefayne

Debre Berhan, Shewa, Ethiopia

M Dessye

Debre Berhan, Shewa, Ethiopia

Outcomes

Primary Outcomes

Changes in Sprint Performance Time

Sprint performance will be assessed using electronic timing gates to record running times over a specific distance from a stationary start. Lower times indicate improved sprint performance. Measurements will be taken at baseline and at the conclusion of the training intervention period to evaluate the impact of the workload protocols.

Time frame: 12 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.